Want to track LXRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lexicon Pharmaceuticals, Inc. (LXRX) Statistics
Valuation metrics
Market Cap 843.97M
Enterprise value 868.03M
Trailing P/E (ttm) -29.3
Forward P/E -
PEG ratio -0.11
Price/Sales (ttm) 12.18
Price/Book (mrq) 3.77
Enterprise Value/Revenue 12.46
Enterprise Value/EBITDA -42.6
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.13M
Average volume (90 days) 2.54M
Price summary
52-Week low 0.64
52-Week high 2.53
Beta -
50-Day moving average 1.93
200-Day moving average 1.55
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:7
Last split Date 21 May 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.37%
Operating margin -0.35%
Operational effectiveness
Return on assets -0.1%
Return on equity -0.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.17
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.43
Total debt (mrq) -
Total Debt/Equity (mrq) 0.28
Current ratio (mrq) 18.79%
Book value per share (mrq) 0.51
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
